Sotorasib Drug Encyclopedia

Sotorasib is a revolutionary anti-cancer drug and belongs to a new generation of targeted drugs in the field of tumor treatment. It is unique in that it targets the G12C G12C mutation in the KRAS gene, a common but difficult-to-treat genetic mutation in many cancers.

KRASgene mutations play a key role in the development of cancer, and the G12C mutation is of particular concern. Sotorasiib inhibits the growth and division of cancer cells by specifically inhibiting the KRAS G12C mutation and interfering with abnormal cell signaling pathways. This revolutionary treatment mechanism provides an unprecedented treatment approach for patients with cancers such as lung cancer with KRAS G12C mutations.

Clinical trial results show that sotoraxib exhibits significant efficacy in the treatment of KRAS G12Cmutated non-small cell lung cancer. After receiving sotorasiib treatment, patients not only significantly prolonged their survival, but also showed positive effects in improving quality of life and alleviating symptoms. This makes sotoracib a highly anticipated innovative treatment, bringing new hope to patients who have long been affected by KRAS mutations.

The successful development and launch of sotoraxib marks a milestone in the field of cancer treatment. Its introduction has opened a new era of treatment for cancer patients, providing new options for many cases that were once unable to be effectively treated. With in-depth research on the efficacy and safety of sotoraxib, it is believed that it will continue to play an important role in the field of tumor treatment and bring more hope and opportunities to patients.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.